Patents by Inventor Juan A. Sanchez

Juan A. Sanchez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7060792
    Abstract: A compound and method for using the compound to reduce injury associated with ischemia and reperfusion of mammalian organs such as the heart. The compound, either Deltorphin A and/or Dermorphin H, may be administered as part of a preconditioning strategy which reduces the extent of injury and improves organ function following cessation and restoration of blood flow. The compound may be used in preparation for planned ischemia or in a prophylactic manner in anticipation of further ischemic events.
    Type: Grant
    Filed: May 31, 2005
    Date of Patent: June 13, 2006
    Assignees: University of Kentucky Research Foundation, Zymogenetics
    Inventors: Peter R. Oeltgen, Paul D. Bishop, Mark S. Kindy, Juan A. Sanchez
  • Patent number: 6900178
    Abstract: A compound and method for using the compound to reduce injury associated with ischemia and reperfusion of mammalian organs such as the heart. The compound, either Deltorphin A and/or Dermorphin H, may be administered as part of a preconditioning strategy which reduces the extent of injury and improves organ function following cessation and restoration of blood flow. The compound may be used in preparation for planned ischemia or in a prophylactic manner in anticipation of further ischemic events.
    Type: Grant
    Filed: September 6, 2001
    Date of Patent: May 31, 2005
    Assignee: University of Kentucky Research Foundation
    Inventors: Peter R. Oeltgen, Paul D. Bishop, Mark S. Kindy, Juan A. Sanchez
  • Patent number: 6645938
    Abstract: A compound and method for using compound-D SEQ ID NO:1 to reduce injury associated with ischemia and reperfusion of mammalian organs such as the heart. The compound may be administered as part of a preconditioning strategy which reduces the extent of injury and improves organ function following cessation and restoration of blood flow. The compound may be used in preparation for planned ischemia or in a prophylactic manner in anticipation of further ischemic events.
    Type: Grant
    Filed: January 10, 2001
    Date of Patent: November 11, 2003
    Assignees: ZymoGenetics, Inc., University of Kentucky Research Foundation
    Inventors: Peter R. Oeltgen, Paul D. Bishop, Mark S. Kindy, Juan A. Sanchez
  • Publication number: 20030109433
    Abstract: A compound and method for using the compound to reduce injury associated with ischemia and reperfusion of mammalian organs such as the heart. The compound, either Deltorphin A and/or Dermorphin H, may be administered as part of a preconditioning strategy which reduces the extent of injury and improves organ function following cessation and restoration of blood flow. The compound may be used in preparation for planned ischemia or in a prophylactic manner in anticipation of further ischemic events.
    Type: Application
    Filed: September 6, 2001
    Publication date: June 12, 2003
    Inventors: Peter R. Oeltgen, Paul D. Bishop, Mark S. Kindy, Juan A. Sanchez
  • Publication number: 20020055468
    Abstract: A compound and method for using compound-D SEQ ID NO:1 to reduce injury associated with ischemia and reperfusion of mammalian organs such as the heart. The compound may be administered as part of a preconditioning strategy which reduces the extent of injury and improves organ function following cessation and restoration of blood flow. The compound may be used in preparation for planned ischemia or in a prophylactic manner in anticipation of further ischemic events.
    Type: Application
    Filed: January 10, 2001
    Publication date: May 9, 2002
    Inventors: Peter R. Oeltgen, Paul D. Bishop, Mark S. Kindy, Juan A. Sanchez
  • Patent number: 6316411
    Abstract: A compound and method for using the compound to reduce injury associated with ischemia and reperfusion of mammalian organs such as the heart. The compound may be administered as part of a preconditioning strategy which reduces the extent of injury and improves organ function following cessation and restoration of blood flow. The compound may be used in preparation for planned ischemia or in a prophylactic manner in anticipation of further ischemic events.
    Type: Grant
    Filed: January 4, 2000
    Date of Patent: November 13, 2001
    Assignees: University of Kentucky Research Foundation, ZymoGenetics
    Inventors: Peter R. Oeltgen, Paul D. Bishop, Mark S. Kindy, Juan A. Sanchez
  • Patent number: 5440862
    Abstract: An automatic fruit container filler machine. Such comprises a structure (1) supporting an electric motor (3) which drives a carriage lift (2) carrying an endless belt (6) having rotary and conveyor movement to form a horizontal belt surface (6b) which can be positioned coplanar with a feeder (16) for a fruit layer (18c) and can then be positioned at a lower level namely at the bottom of the container (17) or the preceding fruit layer. At this position, the belt is retracted, and the fruit layer (18) is deposited at a position (18a) without the layer being hocked or changed.The machine is applicable for filling containers with delicate fruit being extremely sensitive to hocking, such as apples, citrus fruits, tomatoes, peaches and the like.
    Type: Grant
    Filed: August 31, 1994
    Date of Patent: August 15, 1995
    Assignee: Food Machinery Espanola S.A.
    Inventor: Juan A. Sanchez-de-Leon-Rodriguez-Roda